Production & Manufacturing

There are many reasons for pharma and biotech companies for a technology transfer: Some need a back-up strategy for risk management to provide an adequate market supply for the patient. For others, there may be a lack of appropriate resources/capacity...

AveXis, a gene therapy company developing treatments for rare and life-threatening neurological diseases that Novartis bought in an $8.7 billion deal, will be creating 200 jobs as it expands its manufacturing center in Durham County, North Carolina. ...

WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeutics . A global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality...

LabConnect, a leading global provider of central laboratory and support services for biopharmaceutical, medical device, and contract research organizations, is pleased to announce a new service: LabConnect’s global sample processing network (GSPN). This GSPN will offer...

Sharp - a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed its relocation to its $23m state-of-the-art facility in Bethlehem, PA. Sharp acquired the new Bethlehem facility...

Gene therapy-focused biopharma company Orchard Therapeutics has signed a long-term lease agreement to build a third manufacturing facility in Fremont, California. The new facility is expected to open in 2019. The Fremont space will be 150,000...

Recro Gainesville has added a 24,000-square-foot facility, which includes high-potent material processing space, near its existing 97,000-square-foot contract pharmaceutical development and manufacturing plant. The company is a wholly owned subsidiary of Recro Pharma, Inc., and a...